| NMDA receptors, cognition and schizophrenia–testing the validity of the NMDA receptor hypofunction hypothesis G Gilmour, S Dix, L Fellini, F Gastambide, N Plath, T Steckler, J Talpos, ... Neuropharmacology 62 (3), 1401-1412, 2012 | 216 | 2012 |
| Targeting the synapse in Alzheimer’s disease J Jackson, E Jambrina, J Li, H Marston, F Menzies, K Phillips, G Gilmour Frontiers in neuroscience 13, 735, 2019 | 197 | 2019 |
| Coordinated acetylcholine release in prefrontal cortex and hippocampus is associated with arousal and reward on distinct timescales LMTG Ruivo, KL Baker, MW Conway, PJ Kinsley, G Gilmour, KG Phillips, ... Cell reports 18 (4), 905-917, 2017 | 152 | 2017 |
| Prefrontal cholinergic mechanisms instigating shifts from monitoring for cues to cue-guided performance: converging electrochemical and fMRI evidence from rats and humans WM Howe, AS Berry, J Francois, G Gilmour, JM Carp, M Tricklebank, ... Journal of Neuroscience 33 (20), 8742-8752, 2013 | 143 | 2013 |
| A comparison of the effects of ketamine and phencyclidine with other antagonists of the NMDA receptor in rodent assays of attention and working memory JW Smith, F Gastambide, G Gilmour, S Dix, J Foss, K Lloyd, N Malik, ... Psychopharmacology 217, 255-269, 2011 | 128 | 2011 |
| Selective remediation of reversal learning deficits in the neurodevelopmental MAM model of schizophrenia by a novel mGlu5 positive allosteric modulator F Gastambide, MC Cotel, G Gilmour, MJ O'neill, TW Robbins, ... Neuropsychopharmacology 37 (4), 1057-1066, 2012 | 118 | 2012 |
| The effects of intracortical endothelin-1 injections on skilled forelimb use: implications for modelling recovery of function after stroke G Gilmour, SD Iversen, MF O’Neill, DM Bannerman Behavioural brain research 150 (1-2), 171-183, 2004 | 102 | 2004 |
| Measuring reinforcement learning and motivation constructs in experimental animals: relevance to the negative symptoms of schizophrenia A Markou, JD Salamone, TJ Bussey, AC Mar, D Brunner, G Gilmour, ... Neuroscience & Biobehavioral Reviews 37 (9), 2149-2165, 2013 | 96 | 2013 |
| Diverse and often opposite behavioural effects of NMDA receptor antagonists in rats: implications for “NMDA antagonist modelling” of schizophrenia G Gilmour, EY Pioli, SL Dix, JW Smith, MW Conway, WT Jones, S Loomis, ... Psychopharmacology 205, 203-216, 2009 | 96 | 2009 |
| Measuring the construct of executive control in schizophrenia: defining and validating translational animal paradigms for discovery research G Gilmour, A Arguello, A Bari, VJ Brown, C Carter, SB Floresco, ... Neuroscience & Biobehavioral Reviews 37 (9), 2125-2140, 2013 | 91 | 2013 |
| Rats place greater value on rewards produced by high effort: An animal analogue of the “effort justification” effect ES Lydall, G Gilmour, DM Dwyer Journal of Experimental Social Psychology 46 (6), 1134-1137, 2010 | 90 | 2010 |
| Characterisation of carbon paste electrodes for real-time amperometric monitoring of brain tissue oxygen FB Bolger, SB McHugh, R Bennett, J Li, K Ishiwari, J Francois, ... Journal of neuroscience methods 195 (2), 135-142, 2011 | 74 | 2011 |
| A within-subject cognitive battery in the rat: differential effects of NMDA receptor antagonists S Dix, G Gilmour, S Potts, JW Smith, M Tricklebank Psychopharmacology 212, 227-242, 2010 | 68 | 2010 |
| In vitro characterisation of the novel positive allosteric modulators of the mGlu5 receptor, LSN2463359 and LSN2814617, and their effects on sleep architecture and operant … G Gilmour, LM Broad, KA Wafford, T Britton, EM Colvin, A Fivush, ... Neuropharmacology 64, 224-239, 2013 | 65 | 2013 |
| Tracking progressive pathological and functional decline in the rTg4510 mouse model of tauopathy T Blackmore, S Meftah, TK Murray, PJ Craig, A Blockeel, K Phillips, ... Alzheimer's research & therapy 9, 1-15, 2017 | 64 | 2017 |
| Disturbances of sleep quality, timing and structure and their relationship with other neuropsychiatric symptoms in Alzheimer’s disease and schizophrenia: insights from studies … R Winsky-Sommerer, P de Oliveira, S Loomis, K Wafford, DJ Dijk, ... Neuroscience & Biobehavioral Reviews 97, 112-137, 2019 | 63 | 2019 |
| Phenotypic characterization of nonsocial behavioral impairment in neurexin 1α knockout rats. F Esclassan, J Francois, KG Phillips, S Loomis, G Gilmour Behavioral neuroscience 129 (1), 74, 2015 | 62 | 2015 |
| An automated maze task for assessing hippocampus-sensitive memory in mice EY Pioli, BN Gaskill, G Gilmour, MD Tricklebank, SL Dix, D Bannerman, ... Behavioural brain research 261, 249-257, 2014 | 55 | 2014 |
| Temporally distinct cognitive effects following acute administration of ketamine and phencyclidine in the rat F Gastambide, SN Mitchell, TW Robbins, MD Tricklebank, G Gilmour European Neuropsychopharmacology 23 (11), 1414-1422, 2013 | 54 | 2013 |
| α7 and β2 nicotinic acetylcholine receptor subunits form heteromeric receptor complexes that are expressed in the human cortex and display distinct pharmacological properties MS Thomsen, R Zwart, D Ursu, MM Jensen, LH Pinborg, G Gilmour, J Wu, ... PloS one 10 (6), e0130572, 2015 | 52 | 2015 |
Francois GastambideH. Lundbeck A/SVerified email at Lundbeck.com
